Income after Taxes: Earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Lakefront Biotherapeutics - Sponsored ADR (LKFT) Income after Taxes data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Income after Taxes |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$3.70B |
|
$123.46M |
|
$408.99M |
|
$4.11B |
|
$428.48M |
|
-- |
|
$816.35M |
|
$1.24B |
|
$2.86B |
|
$2.85B |
|
$2.86B |
|
-- |
|
| Cash Flow Statement Financials | |
$-245.46M |
|
$252.71M |
|
$-3.35M |
|
$75.09M |
|
$75.34M |
|
$0.26M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|